Toxic shock syndrome: Causes in people with burn wounds

Wounds UK

Volumn 2, Issue 4, 2006, Pages 66-73

  Edwards Jones, Valerie ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Burn wounds; Staphylococcus aureus; Toxic shock syndrome

Indexed keywords

ENTEROTOXIN; EXOTOXIN; TOXIN ANTIBODY;

BACTERIAL COLONIZATION; BACTERIAL STRAIN; BURN INFECTION; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; HUMAN; IMMUNITY; INCIDENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SYMPTOMATOLOGY; TAMPON; TOXIC SHOCK SYNDROME; WOUND INFECTION;

EID: 33845449006     PISSN: 17466814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Allen ST, Liland JB, Nichols CG, Glew RH (1990) Toxic shock syndrome associated with the use of nasal packing. Arch Int Med 150: 2587-8
2. Arnold J, Lucarelli M, Cutrona AF, DiDomenico LA, Karlock L (2001) Toxic Shock Syndrome originating from the foot. J Foot Ankle Surg 40: 411-3
3. Arvidson S, Tegmark K (2001) Regulation of virulence determinants in Staphylococcus aureus. Int J Med Microbiol 291: 159-70
4. Astiz ME, Rackhow EC (1998) Septic shock. Lancet 351: 1501-5
5. Baker BS (2006) The role of microorganisms in atopic dermatitis. Clin Exp Immunol 144(1): 1-9
6. Balaban N, Novick RP (1995) Autocrine regulation of toxin synthesis by Staphylococcus. Proc Natl Acad Sci USA 92 (5): 1619-23
7. Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G (2005) Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Relat Res 437: 48-54
8. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with Toxic Shock Syndrome Staphylococcus aureus isolates. Lancet 1: 1017-21
9. Bergdoll MS, Schlievert PM (1984) Toxic shock syndrome toxin. Lancet 2: 691
10. Best GK, Scott DF, Kling MJ, Thompson MR, Adinolfe LE, Bonventre PF (1988) Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS Toxin-1, specific monoclonal antibody. Infect Immun 56: 998-9
11. Bonventre PF, Linnemann C, Weckback LS et al (1984) Antibody responses to toxic shock syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis 150: 662-6
12. British National Formulary (1994) British National Formulary Number 28. British Medical Association and the Royal Pharmaceutical Society of Great Britain, London: 464-5
13. Buck R, Dawson MM, Shawcross SG, Edwards-Jones V (2000) The Effect of Wound Dressings on Exotoxin Production by Staphylococcus Aureus. Proceedings of the 9th International Symposium of Staphylococci and Staphylococcal Infection, Kolding Denmark.
14. Buck R, Dawson MM, Shawcross SG, Edwards-Jones V (2002) The Development of A Semi-solid System to Assess the Effect of Wound Dressings on TSST-1 Production. Proceedings of the British Burns Association conference, Birmingham UK
15. Chesney PJ, Davis JP, Purdy WK, Wand PJ, Chesney RW (1981) Clinical manifestations of Toxic Shock Syndrome. JAMA 246: 741-8
16. Childs C, Edwards-Jones V, Heathcote DM et al (1994) Patterns of S. aureus colonisation, toxin production, immunity and illness in burned children. Burns 20: 514-21
17. Childs C, Dawson MM, Edwards-Jones V (1999) Toxic shock syndrome toxin-1 antibodies in burned children. Burns 25: 473-6
18. Crass BA, Bergdoll MS (1986) Toxin involvement in Toxic Shock Syndrome. J Inf Dis 153: 918-26
19. Davis JP, Chesney PJ, Wand PJ, La-Ventre M (1980) Toxic shock syndrome: Epidemiological features recurrence risk factors and prevention. New Eng J Med 303: 1429-35
20. Drake CG, Kotzin BL (1992) Superantigens: Biology, Immunology and potential role in disease. J Clin Immun 12: 149-62
21. Edwards-Jones V, Foster HA (1994) The effect of topical antimicrobial agents on the production of toxic shock syndrome toxin-1. J Med Microbiol 41(6): 408-13
22. Edwards-Jones V, Childs C, Foster HA (1996) A comparison of isolates of S. aureus from burned patients and other patient groups. Burns 22: 384-9
23. Edwards-Jones V, Shawcross S (1997) Toxic shock syndrome in the burned patient. Br J Biomed Sci 54: 110-7
24. Edwards-Jones V, Dawson MM, Childs CA (2000) Survey into TSS in UK Burn Units. Burns 26: 323-3
25. Edwards-Jones V, Foster HA (2002) The effects of silver sulphadiazine on the production of exoproteins by S. aureus. J Med Micro 51(1): 50-5
26. Egan WC, Clark WR (1988) The Toxic Shock Syndrome in a burned victim. Burns 14: 135-8
27. Farmer BA, Bradley JS, Smiley PW (1985) Toxic shock syndrome in a scald burn victim. J Trauma 25: 1004-6
28. Hajjeh RA, Reingold A, Weil A, Shutt K, Schuchat A, Perkins BA (1999) Toxic shock syndrome in the United States: surveillance update, 1979-1996. Emerg Infect Dis 5: 807-10
29. Iwatsuki K, Yamasaki O, Morizane S, Oono T (2006) Staphylococcal cutaneous infections; Invasion, evasion and aggression. J Dermatol Sci 42: 203-14
30. Fleischer B (1994) Superantigens. Beh Inst Miett 94: 104-12
31. Frame JD, Eve MD, Hackett MEJ, et al (1985) The Toxic Shock Syndrome in burned children. Burns 11: 234-41
32. Gahrn-Hansen B, Lundicvist L, Nielson E (1989) Pyomyositis and probable toxic shock syndrome caused by a toxin-1 producing strain of Staphylococcus aureus. Eur J Clin Micro Infect Dis 8: 89-90
33. Gordon AE, MacKenzie DA, El Ahmer OR et al (2002) Evidence for a genetic component in sudden infant death syndrome. Child Care Health Dev 28 Suppl 1: 27-9
34. Holland KT, Timmins B, Wright J, Davis W (1998) Does the microflora of the vagina modulate expression of tst by S. aureus? In: Arbuthhnott J, Furman B eds. European Conference on Toxic Shock Syndrome International Congress and Symposium series 229. RSM Press, London: 118-20
35. Holmes CL, Russell JA, Walley KR (2003) Genetic polymorphisms in sepsis and septic shock; role prognosis and potential for therapy. Chest 124: 1103-15
36. Jacobson JA, Kasworm E, Daly JA (1989) Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin-1 following non-genital staphylococcal infection. Rev Infect Dis 11(Suppl 1): S8-S13
37. Ji GY, Beavis RC, Novick RP (1995) Cell-density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc Natl Acad Sci USA 92: 12055-9
38. Johnson D, Pathirana PDR (2002) Toxic Shock Syndrome following cessation of prophylactic antibodies in a child with a 2% scald. Burns 28: 181-4
39. Kass EH, Kendrick MI, Tsai YC Parsonnet J (1987) Interaction of magnesium ion, oxygen tension and temperature in the production of toxic shock syndrome toxin-1 by S. aureus. J Infect Dis 155: 812-5
40. Kotzin BL, Leung DYM, Kappler J, Marrack P (1993) Superantigens and their potential role in human disease. Adv Immun 54: 99-166
41. Kotb M (1995) Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 8: 411-26
42. Lawrence JC (1992) Burn bacteriology during the last 50 years. Burns 18(suppl2): S23-29
43. Lee AC, Crass BA, Bergdoll MS (1987) Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin-1 by S.aureus. J Clin Microbiol 25: 87-90
44. Llewelyn M, Sriskandan S, Terrazzini N, Cohen J, Altmann DM (2006) The TcR Vb signature of bacterial superantigens spreads stimulus strength. Int Immunol 18: 1433-41
45. Lyon GJ, Novick RP (2004) Peptide signaling in Staphylococcus aureus and other Gram-positive bacteria. Peptides 25: 1389-403
46. Marples RR, Weineke AA (1994) Toxic shock syndrome and related conditions in the United Kingdom 1992-1993. CDR 4: R1
47. Martin JM, Green M (2006) Group A streptococcus. Semin Pediatr Infect Dis 17: 140-8
48. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and relatives. Science 248: 705-11
49. Masaki F, Gozo N, Yuichi H et al (2004) Fatal possible toxic shock syndrome in an adult following 15% scald burn. Burns 30: 181-4
50. Matsuda Y, Kato H, Yamada R et al (2003) Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T-cell receptor Vb2-postive T cells. Emerg Infect Dis 3: 387-9
51. McAllister RMR, Mercer NSG, Mercer BDG, Sanders R (1993) Early diagnosis of staphylococcal toxaemia in burned children. Burns 19: 22-5
52. Michie CA, Davis T (1996) Atopic dermatitis and staphylococcal superantigens. Lancet 347(8997): 324
53. Morishita Y, Tada J, Sato A, et al (1999) Possible influences of Staphylococcus aureus on atopic dermatitis - the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy 29: 1110-7
54. Muir IFK, Barclay TL (1962) Burns and Their Treatment. Lloyd-Luke, London
55. Musser JM, Schlievert PM, Chow AW et al (1990) A single clone of S. aureus causes the majority of cases of toxic shock syndrome. Proc of the Natl Acad Sci USA 87: 225-9
56. Newbould MJ, Malam J, McIllmurray JM, Morris JA, Telford DR, Barson AJ (1989) Immunohistological localisation of staphylococcal toxic shock syndrome toxin (TSST-1) antigen in sudden infant death syndrome. J Clin Pathol 42: 935-9
57. Notermans S, Van Leeuwen WJ, Dufrenne J, Tips PD (1983) Serum antibodies to enterotoxins produced by S.aureus with special reference to enterotoxin F and toxic shock syndrome. J Clin Microbiol 18: 1055-60
58. Novick RP, Kornblum J, Krieswirth BN, Projan S, Ross H (1989) Agr: a complex locus regulating post exponential phase exoprotein synthesis in S.aureus. In: Butler LO, Harwood C, Moseley BEB eds. Genetic Transformation and Expression. Intercept Ltd, Andover: 495-510
59. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S (1993) Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J 12: 3967-75
60. Papini RPG, Wilson APR, Steer JA, McGrouther DA, Parkhouse N (1995) Wound management in burn centres in the United Kingdom. Br J Surg 82: 505-9
61. Rashid A, Brown AP, Khan K (2005) On the use of prophylactic antibiotics in prevention of Toxic Shock Syndrome. Burns 31: 981-5
62. Reeves MW (1989) Effect of trace metals on the synthesis of toxic shock syndrome toxin-1. Rev Infect Dis 11(Suppl 1): 145-50
63. Reingold AL, Hargrett NT, Dan DB, Shands KN, Strickland BY, Broome CV (1982) Non-menstrual toxic shock syndrome. A review of 130 cases. Ann Intern Med 96(part 2): 871-4
64. Roggiani M, Schlievert PM (1994) Streptococcal toxic shock syndrome, including necrotizing fasciitis and myocitis Curr Opin Infect Dis 7: 423-6
65. Sarafian SK, Morse BA (1987) Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis. J Med Microbiol 24: 75-81
66. Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD (1981) Identification and characterisation of an exotoxin from Staphylococcus aureus associated with Toxic Shock Syndrome. J Infect Dis 143: 509-16
67. Schlievert PM, Blomster DA, Kelly JA (1984) Effect of tampons on growth and production of TSS exotoxin. Obstet Gynecol 64: 666-74
68. Sergent P, Edwards-Jones V (1996) The effect of mixed culture on the production of toxins by Staphylococcus aureus. In: Proceedings of the 8th International Symposium on Staphylococci and Staphylococcal Infections. Aix les Bains, France
69. Schuchat A, Broome CV (1991) Toxic shock syndrome and tampons. Epidemiol Rev 13: 99-112
70. Takei S, Arora YK, Walker SM (1993) Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigen. J Clin Invest 91: 602-7
71. Todd JK, Fishalt M, Kapral F, Welch T (1978) Toxic Shock Syndrome associated with phage group 1 staphylococci. Lancet ii: 1116-8
72. Todd JK, Todd H, Franco-Buff A, Smith CM, Lawellin DW (1987) Influence of focal growth conditions on the pathogenesis of toxic shock syndrome. J Infect Dis 155: 673-81
73. Tripathi A, Kern R, Conley DB et al (2005) Staphylococcal exotoxins and nasal polyposis: analysis of systemic and local responses. Am J Rhinol 19: 327-33
74. Vergeront JM, Stolz SJ, Crass BA, Nelson DB, Davis JP, Bergdoll MS (1983) Prevalence of serum antibody to Staphylococcal enterotoxin F among Wisconsin residents: implications for toxic shock syndrome. J Infect Dis 148: 692-8
75. Weinzweig J, Gottlieb LJ, Krizek TI (1994) Toxic shock syndrome associated with the use of Biobrane in a scald burn victim. Burns 20: 180-1
76. Williams P, Camara M, Hardman A et al (2000) Quorum sensing and the population-dependent control of virulence. Philos Trans R Soc Lond B Biol Sci 29: 667-80
77. Withey SJ, Carver N, Frame JD, Walker CC (1999) Toxic Shock Syndrome in adult burns. Burns 25: 659-62
78. Wong ACL, Bergdoll MS (1990) Effect of environmental conditions on production of toxic shock syndrome toxin 1 by S. aureus. Infect Immun 58: 1026-9
79. Yaqoob M, McClelland P, Murray AE, Mostafa SM, Ahmad R (1990) Staphylococcal enterotoxin-A and enterotoxin-C causing toxic shock syndrome. J Infect 20: 176-8